Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy.
Willemsen M, Bulgarelli J, Chauhan SK, Lereim RR, Angeli D, Grisendi G, Krebbers G, Davidson I, Kyte JA, Guidoboni M, Luiten RM, Bakker WJ.
Willemsen M, et al. Among authors: lereim rr.
Immunooncol Technol. 2024 Nov 15;24:101009. doi: 10.1016/j.iotech.2024.101009. eCollection 2024 Dec.
Immunooncol Technol. 2024.
PMID: 39697983
Free PMC article.